SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing
SciSparc Ltd. (SPRC)
Company Research
Source: GlobeNewswire
The SCI- 210 treatment is now available at clinical site for autism spectrum disorder clinical trial in pediatric patients, in accordance with enrollment initiation TEL AVIV, Israel, Feb. 29, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, today announced that it has successfully completed the manufacturing of and delivered its innovative SCI- 210 treatment, in accordance with its initiation of enrollment for the clinical trial at the Soroka Medical Center of pediatric patients who have Autism Spectrum Disorder ("ASD"). The Company's proprietary SCI- 210 treatment combines cannabidiol-rich oil (“CBD”) and CannAmide™, SciSparc’s proprietary palmitoylethanolamide-based tablets. "A clinical trial is a complicated project composed of many little steps- which in turn help ensur
Show less
Read more
Impact Snapshot
Event Time:
SPRC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SPRC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SPRC alerts
High impacting SciSparc Ltd. news events
Weekly update
A roundup of the hottest topics
SPRC
News
- SciSparc to acquire vehicle importer AutoMax [Seeking Alpha]Seeking Alpha
- SciSparc to Acquire AutoMax [Yahoo! Finance]Yahoo! Finance
- SciSparc to Acquire AutoMaxGlobeNewswire
- Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression [Yahoo! Finance]Yahoo! Finance
- SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating DepressionGlobeNewswire
SPRC
Sec Filings
- 4/12/24 - Form 425
- 4/11/24 - Form 6-K
- 4/1/24 - Form S-8
- SPRC's page on the SEC website